Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.
Thank you for visiting our Giving Page to support our research projects. Our goal is to drive personalized medical advances for individualized cancer treatment plans.
1) Discovery and engineering of T cells against fusion-positive sarcomas. Using single-cell genomics to identify sarcoma targetting T cells in patient samples, and then use CRISPR/Cas9 to engineer specific T cells for cellular therapies. (all gifts made through this page starting January 2022 support this project)
2) Managed under the Pediatric Hematologic Malignancy Program using cutting-edge CRISPR-based cancer research creating new functional genomics library using state-of-the-art, tunable screening approaches such as RNAi to control for off-target effects. (all gifts made through this page 2020-2021 supported this project)
Dana-Farber provides expert, compassionate care to children and adults and is home to groundbreaking cancer discoveries. Since its founding in 1948, the Jimmy Fund has raised millions of dollars through thousands of community efforts to advance Dana-Farber’s mission.
The Selig family's first PMC ride was in 1991. We have been supporting Dana Farber and the Jimmy Fund for over 30 years. Given our recent family experience over the past several years, we have decided to narrowcast our efforts. Based on our personal insights the need to move more towards a uniquely personalized medical experience will be key to driving positive patient outcomes now and in the future.
Our fund was created to design and build new approaches to treatment in pediatric cancer.